• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AAN 2018

Update on oral cladribine – Effect on lymphocytes and safety data

May 9, 2018  

AAN 2018 DAILY REPORT

April 26, 2018  

Browse by Topic

MS (342)
AD (82)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
EPILEPSY (22)
STROKE (22)
BIOMARKERS IN MS (21)
Library (13)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2019 (10)
ECTRIMS 2021 (10)
CLINICAL CASES IN MS (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (9)
MS SEQUENCING (9)
AAN 2013 (9)
AAN 2014 (9)
ECTRIMS 2013 (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2021 (6)
ECTRIMS 2017 (6)
CHARCOT 2013 (6)
ECTRIMS 2022 (6)
ANXIETY (5)
ECTRIMS 2016 (5)
AAN 2022 (5)
BIPOLAR (5)
CCSVI (5)
BPD (4)
NeuroSound (4)
AAN 2023 (4)
EAN 2015 (4)
ENS 2013 (3)
PAIN (3)
AAN 2017 (3)
EAN 2022 (3)
AAN 2020 (3)
SLEEP (2)
EAN 2020 (2)
APA 2014 (2)
SPECIAL REPORT (2)
AAN 2018 (2)
NEW DRUGS (2)
EAN 2021 (1)
SEIZURE (1)
ACTRIMS 2022 (1)
APA 2016 (1)
LGS (1)
TSC (1)
LUMBAR PUNCTURE (1)
ACTRIMS 2023 (1)
ALS (1)
hATTR (1)
INSOMNIA (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ADDICTION (1)
EAN 2019 (1)
AAN 2016 (1)
WEST NILE (1)
GUIDELINES (1)
EAN 2016 (0)
BIOMARKERS (0)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Progression independent of relapses (PIRA) in MS posted on November 21, 2019
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions